National Coalition for LGBT Health-LGBT Health Training and Certificate Program(TM)

The National Coalition for LGBT Health is proud to announce the LGBT Health Training and Certificate Program™ — a professional development offering for clinical and allied health care providers and support staff to cultivate new skills and gain critical knowledge to enhance the delivery of quality, culturally competent care to lesbian, gay, bisexual, and transgender consumers. This program will include a comprehensive series of modules on LGBT health education, focusing on care provision, service delivery, and health systems. This web-based educational program covers a variety of LGBT health issues and needs. Topics include sexual orientation and gender identity, cultural competency, health disparities across racial and ethnic communities, and LGBT friendly health systems. After completing a final exam, participants will receive a Certificate of Proficiency in LGBT Health reflecting their completion of this program from The National Coalition for LGBT Health.

Register

Module 1: Building Trust with LGBT Clients

Start Date: 8/10/2015
Expiration Date: 8/31/2017

Activity Length: The estimated time to complete this activity is 1.5 hours.

LGBT health centers and advocacy organizations have led the way in building clinical programs and best practices that have uniquely addressed the needs of their diverse populations, such as transgender individuals, racial and ethnic LGBT minorities, gay and bisexual men at increased risk for HIV, and LBTQ women. During LGBT Health Awareness Week, the National Coalition for LGBT Health is highlighting four of these programs, which have built trust with LGBT clients. The webinar will provide recommendations and insights for health centers and medical providers on building trustful relationships with LGBT clients.

AGENDA

TOPIC
FACULTY
Transgender Health
Nurit Shein
Chief Executive Officer
Mazzoni Center
Philadelphia, PA
Racial and Ethnic LGBT Minority Health
Luis Freddy Molano, MD
Vice President of Infectious Diseases and LGBTQ Programs
Community Healthcare Network
New York, NY
Gay/Bisexual Men’s Health
John Stryker, NP
Howard Brown Health Center
Chicago, IL
LBTQ Women’s Health
Liz James
Chief Executive Officer
Lesbian Health Initiative (LHI)
Houston, TX

LEARNING OBJECTIVES
Upon completion of this activity, learners will be able to:

– Discuss the concepts of sexual orientation and gender identity, and use appropriate terminology with LGBT patients

– Illustrate social determinants of health, and specifically those impacting the prevention and treatment of HIV

– Utilize practical approaches to improve LGBT cultural competence in their own practices

– Describe stigma’s impact on the HIV continuum of care

– Demonstrate accepting behaviors toward LGBT diversity including appropriate questions to uncover individual patient’s preference

– Implement effective strategies for HIV prevention

TARGET AUDIENCE
This activity is intended for MDs, DOs, PAs, and NPs; other healthcare providers such as social workers, nurses, medical assistants, community-based organization leaders, AIDS service organization leaders, and staff members also are encouraged to participate.

 

PROVIDER STATEMENT
This activity is jointly provided by National Coalition for LGBT Health and Postgraduate Institute for Medicine.

LGBT_LG PIM

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and National Coalition for LGBT Health.  Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CME credit for this activity. During the period August 10, 2015 through August 31, 2017, participants must read the learning objectives and faculty disclosures and study the educational activity.

If you wish to receive acknowledgment for completing this activity, please complete the online post-test and evaluation upon completion of online course.  Upon successful completion of the post-test, with a passing score of 75% or better, and the online activity evaluation, your certificate will be made available immediately.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

NAME OF FACULTY OR PRESENTER RELATIONSHIP
REPORTED FINANCIAL
Nurit Shein
Chief Executive Officer
Mazzoni Center
Has no relevant financial relationships to disclose.
Luis Freddy Molano, MD
Vice President of Infectious Diseases and LGBTQ Programs
Community Healthcare Network
Has no relevant financial relationships to disclose.
John Stryker, NP
Howard Brown Health Center
Consulting Fees: Gilead Advisory Board
Liz James
Chief Executive Officer
Lesbian Health Initiative
Has no relevant financial relationships to disclose.

The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following HealthHIV staff, Brian Hujdich and Ryan Meyer, MPP, state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the

planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

COURSE VIEWING REQUIREMENTS

 

Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8Google Chrome 18.0+ for Windows, Mac OS, or Linux Mozilla Firefox 13.0+ for Windows, Mac OS, or Linux Safari 4.0+ for Mac OSX 10.5 and above
Supported Phones & Tablets:
Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above

Module 2: OUTcompetent - Cultural Competency and the Stigmatization of STDs, HIV, PrEP, and Mental Health

Start Date: 4/30/2016
Expiration Date: 4/30/2017

Activity Length: The estimated time to complete this activity is 1.25 hours.

This module will discuss the impact of stigma in STDs, HIV, PrEP, and mental health that LGBT individuals face when accessing healthcare. The module also will equip attendees to effectively engage LGBT individuals who seek care in the areas of STDs, HIV, PrEP, and mental health.

AGENDA

TOPIC
FACULTY
STDs
Stephen Hicks
Health Equity and Capacity Building Manager
National Coalition of STDs Directors (NCSD)
Washington, D.C.
HIV
Venton C. Jones, Jr. 
Program Officer, LGBT Health and Wellness Initiatives
National Black Justice Coalition
Washington, D.C.
PrEP
Damon Jacobs
Licensed Marriage and Family Therapist and HIV Prevention Specialist
New York, NY
Mental Health 
Adam Swanson, MPP
Senior Policy Associate
National Council for Behavioral Health
Washington, D.C.

 

LEARNING OBJECTIVES
Upon completion of this activity, learners will be able to:

– Explain how stigma around STDs, HIV, and PrEP is associated with negative health outcomes for LGBT individuals.

– Discuss how services for LGBT individuals need to be grounded in affirmative and inclusive approaches to care.

– Identify 3 ways that providers and social services organizations can infuse LGBTQ cultural competency into their services in order to best meet the needs of LGBTQ individuals.

 

 

TARGET AUDIENCE
The program has been designed to meet the educational needs of clinical providers (Medical Doctors, Doctors of Osteopathy, Nurse Practitioners, and Physician Assistants) and other allied healthcare professionals who treat and care for LGBT patients.

 

PROVIDER STATEMENT
This activity is jointly provided by HealthHIV and Postgraduate Institute for Medicine, in collaboration with the National Coalition for LGBT Health.

LGBT_LG PIM

 

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and HealthHIV.  Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

 

CREDIT DESIGNATION

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other participants will receive a certificate of participation upon successful completion of the module.

 

METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CME credit for this activity. During the period April 30, 2016 through April 30, 2017, participants must read the learning objectives and faculty disclosures and study the educational activity.

To successfully complete this module, you must:
– View entire activity;
– Score a minimum of 80% on the post-examination and evaluation

During the post-examination, you have three opportunities to answer each question. Participants must receive a score of 80% or higher on the post-examination and complete the evaluation to successfully complete the module. You will not be able to retake the module in the event you score less than 80% on the post-examination.

After successfully completing a module, your certificate will be emailed to you at the email address you provided at registration.
The certificate awarded is based on the profession (i.e., MD, DO, APRN, PA, etc.) under which you registered. If an activity does not offer continuing education credit specifically for your profession, you will received a general certificate of participation.

 

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

NAME OF FACULTY OR PRESENTER RELATIONSHIP
REPORTED FINANCIAL
Stephen Hicks
Has no relevant financial relationships to disclose.
Venton Jones, Jr.
Has no relevant financial relationships to disclose.
Damon Jacobs
Consulting fees: Gilead
Adam Swanson, MPP
Has no relevant financial relationships to disclose.

 

The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following HealthHIV planners and managers, Ryan Meyer, and Brian Hujdich, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

 

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

 

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

 

COURSE VIEWING REQUIREMENTS

 

Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8Google Chrome 18.0+ for Windows, Mac OS, or Linux Mozilla Firefox 13.0+ for Windows, Mac OS, or Linux Safari 4.0+ for Mac OSX 10.5 and above
Supported Phones & Tablets:
Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above

 

Module 3: Healthcare Stigma Facing Transgender Individuals: From Access to Policy and Care to Treatment

Start Date: 6/6/2016
Expiration Date: 6/6/2017

Activity Length: The estimated time to complete this activity is 1.5 hours.

This module covers the impact of stigma on transgender individuals in healthcare settings. The module also will equip attendees to effectively engage transgender individuals who seek care.

AGENDA

TOPIC
FACULTY
Data collection, access to care, and HIV prevention and care for transgender individuals
Danielle Castro
Project Director
Center of Excellence for Transgender Health
San Francisco, CA
LGBTQ cultural competency requirements for providers
Alison Gill
Senior Partner
The Parallax Group
Washington, D.C.
Legal protections for transgender individuals, Section 1557, and the ACA
Omar Gonzalez-Pagan
Staff Attorney
Lambda Legal
New York, NY
Insurance practices impacting access to care for transgender individuals
Anand Kalra
Health Program Manager
Transgender Law Center
Oakland, CA

LEARNING OBJECTIVES
Upon completion of this activity, learners will be able to:

 – Explain the importance of cultural competency on LGBTQ health outcomes.

 – Identify requirements for a minimal level of training relevant to LGBTQ communities.

 – Describe best practices in HIV prevention and care for Transgender individuals.

 

TARGET AUDIENCE
This activity has been designed to meet the educational needs of physicians and other health care providers involved in the care of patients with HIV.

 

PROVIDER STATEMENT
This activity is jointly provided by HealthHIV and Postgraduate Institute for Medicine, in collaboration with the National Coalition for LGBT Health.

LGBT_LG PIM

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and HealthHIV.  Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other participants will receive a certificate of participation upon successful completion of the module.

METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CME credit for this activity. During the period June 6, 2016 through June 6, 2017, participants must read the learning objectives and faculty disclosures and study the educational activity.

To successfully complete this module, you must:
– View entire activity;
– Score a minimum of 80% on the post-examination and evaluation

During the post-examination, you have three opportunities to answer each question. Participants must receive a score of 80% or higher on the post-examination and complete the evaluation to successfully complete the module. You will not be able to retake the module in the event you score less than 80% on the post-examination.

After successfully completing a module, your certificate will be emailed to you at the email address you provided at registration.
The certificate awarded is based on the profession (i.e., MD, DO, APRN, PA, etc.) under which you registered. If an activity does not offer continuing education credit specifically for your profession, you will received a general certificate of participation.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

NAME OF FACULTY OR PRESENTER RELATIONSHIP
REPORTED FINANCIAL
Danielle Castro
Has no relevant financial relationships to disclose.
Alison Gill
Has no relevant financial relationships to disclose.
Omar Gonzalez-Pagan
Has no relevant financial relationships to disclose.
Anand Kalra
Has no relevant financial relationships to disclose.

The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following HealthHIV planners and managers, Ryan Meyer, and Brian Hujdich, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

COURSE VIEWING REQUIREMENTS

 

Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8Google Chrome 18.0+ for Windows, Mac OS, or Linux Mozilla Firefox 13.0+ for Windows, Mac OS, or Linux Safari 4.0+ for Mac OSX 10.5 and above
Supported Phones & Tablets:
Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above

CONTACT

For additional information about HealthHIV’s programs, initiatives, or coalitions, please click here to email, or call 202.232.6749.